Fundamentals of pulmonary drug delivery

Respiratory Medicine

Volumn 97, Issue 4, 2003, Pages 382-387

  Groneberg, D A ^a,b   Witt, C ^a   Wagner, U ^c   Chung, K Fan ^b   Fischer, A ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Aerosol; Airways; Drug; Transport

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; ARTIFICIAL LUNG SURFACTANT; BACTERIAL VACCINE; INSULIN; PENICILLIN G; PENTAMIDINE; PEPTIDE DERIVATIVE; PROSTAGLANDIN DERIVATIVE; PROTEINASE; RIBAVIRIN; STEROID; TRYPSIN; VIRUS VACCINE;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ARTICLE; BRONCHIECTASIS; CILIATED EPITHELIUM; CYSTIC FIBROSIS; CYTOLOGY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG TARGETING; DRUG TRANSPORT; DRUG UPTAKE; DRY POWDER; HUMAN; IDIOPATHIC RESPIRATORY DISTRESS SYNDROME; LUNG ALVEOLUS; LUNG ALVEOLUS CELL TYPE 1; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS PROTEINOSIS; LUNG CLEARANCE; LUNG DIFFUSION; LUNG FIBROSIS; METERED DOSE INHALER; MUCOCILIARY CLEARANCE; NEBULIZER; PARTICLE SIZE; POWDER INHALER; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY EPITHELIUM; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION;

EID: 0037385148     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1457     Document Type: Article

References (63)

1. Groneberg DA, Nickolaus M, Springer J, Doring F, Daniel H, Fischer A. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am J Pathol 2001; 158: 707-714.
2. Groneberg DA, Eynott PR, Doring F, et al. Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung. Thorax 2002; 57: 55-60.
3. Rubin BK, Fink JB. Aerosol therapy for children. Respir Care Clin N Am 2001;7: 175-213, v.
4. Flume P, Klepser ME. The rationale for aerosolized antibiotics. Pharmacotherapy 2002; 22(3 Part 2): 71S-79S.
5. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med 1996; 124: 820-824.
6. Klonoff DC. Inhaled insulin. Diabetes Technol Ther 1999;1: 307-313.
7. Yoshida H, Okumura K, Hori R, Anmo T, Yamaguchi H. Absorption of insulin delivered to rabbit trachea using aerosol dosage form. J Pharm Sci 1979; 68: 670-671.
8. Wigley FW, Londono JH, Wood SH, Shipp JC, Waldman RH. Insulin across respiratory mucosae by aerosol delivery. Diabetes 1971; 20: 552-556.
9. Patton JS, McCabe JG, Hansen SE, Daugherty AL. Absorption of human growth hormone from the rat lung. Biotechnol Ther 1989;1: 213-228.
10. Weibel ER. Morphometry of the human lung: the state of the art after two decades. Bull Physiopathol Respir (Nancy) 1979; 15: 999-1013.
11. Hirai K, Ogawa K. Cytochemical quantitation of cytochrome oxidase activity in rat pulmonary alveolar epithelial cells and possible defect in type I cells. J Electron Microsc (Tokyo) 1986; 35: 19-28.
12. Mason RJ, Crystal RG. Pulmonary cell biology. Am J Respir Crit Care Med 1998; 157(4 Part 2): S72-S81.
13. Sorokin SP. Properties of alveolar cells and tissues that strengthen alveolar defenses. Arch Intern Med 1970; 126: 450-463.
14. Gil J, Silage DA, McNiff JM. Distribution of vesicles in cells of air-blood barrier in the rabbit. J Appl Physiol 1981; 50: 334-340.
15. Gil J. Number and distribution of plasmalemmal vesicles in the lung. Fed Proc 1983; 42: 2414-2418.
16. Low F. Electron microscopy of the rat lung. Anat Rec 1952;113:437-443.
17. Wangensteen OD, Wittmers LE Jr, Johnson JA. Permeability of the mammalian blood-gas barrier and its components. Am J Physiol 1969; 216: 719-727.
18. Taylor AE, Gaar KA Jr. Estimation of equivalent pore radii of pulmonary capillary and alveolar membranes. Am J Physiol 1970; 218: 1133-1140.
19. Inoue S, Michel RP, Hogg JC. Zonulae occludentes in alveolar epithelium and capillary endothelium of dog lungs studies with the freeze-fracture technique. J Ultrastruct Res 1976; 56: 215-225.
20. Inoue S, Hogg JC. Freeze-etch study of the tracheal epithelium of normal guinea pigs with particular reference to intercellular junctions. J Ultrastruct Res 1977; 61: 89-99.
21. Nguyen DA, Neville MC. Tight junction regulation in the mammary gland. J Mammary Gland Biol Neoplasia 1998; 3: 233-246.
22. Nguyen DA, Parlow AF, Neville MC. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol 2001; 170: 347-356.
23. Lippmann M, Yeates DB, Albert RE. Deposition, retention, and clearance of inhaled particles. Br J Ind Med 1980; 37: 337-362.
24. Lippmann M, Albert RE. The effect of particle size on the regional deposition of inhaled aerosols in the human respiratory tract. Am Ind Hyg Assoc J 1969; 30: 257-275.
25. Ariyananda PL, Agnew JE, Clarke SW. Aerosol delivery systems for bronchial asthma. Postgrad Med J 1996; 72: 151-156.
26. Martonen TB, Katz IM. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters. Pharm Res 1993; 10: 871-878.
27. Martonen TB. Deposition patterns of cigarette smoke in human airways. Am Ind Hyg Assoc J 1992; 53: 6-18.
28. Hickey AJ, Martonen TB. Behavior of hygroscopic pharmaceutical aerosols and the influence of hydrophobic additives. Pharm Res 1993; 10: 1-7.
29. Vincent JH, Johnston AM, Jones AD, Bolton RE, Addison J. Kinetics of deposition and clearance of inhaled mineral dusts during chronic exposure. Br J Ind Med 1985; 42: 707-715.
30. Vincent JH, Johnston WB, Jones AD, Johnston AM. Static electrification of airborne asbestos: a study of its causes, assessment and effects on deposition in the lungs of rats. Am Ind Hyg Assoc J 1981; 42: 711-721.
31. Dalby RN, Byron PR. Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions. Pharm Res 1988; 5: 36-39.
32. Swift DL. Aerosols and humidity therapy. Generation and respiratory deposition of therapeutic aerosols. Am Rev Respir Dis 1980; 122(5 Part 2): 71-77.
33. Ferron GA. Aerosol properties and lung deposition. Eur Respir J 1994; 7: 1392-1394.
34. Dolovich M, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 1983; 84: 36-41.
35. Newman SP, Pavia D, Garland N, Clarke SW. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl 1982; 119: 57-65.
36. Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis 1981; 62: 3-21.
37. Schlesinger RB, Lippmann M. Particle deposition in the trachea: in vivo and in hollow casts. Thorax 1976; 31: 678-684.
38. Pavia D, Thomson ML, Clarke SW, Shannon HS. Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax 1977; 32: 194-197.
39. Thompson PJ. Drug delivery to the small airways. Am J Respir Crit Care Med 1998; 157(5 Pt 2): S199-S202.
40. Newman SP. Aerosol generators and delivery systems. Respir Care 1991; 36: 939-951.
41. Newman SP, Wilding IR, Hirst PH. Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products? Int J Pharm 2000; 208: 49-60.
42. Blake JR, Sleigh MA. Mechanics of ciliary locomotion. Biol Rev Camb Philos Soc 1974; 49: 85-125.
43. Serafini SM, Michaelson ED. Length and distribution of cilia in human and canine airways. Bull Eur Physiopathol Respir 1977; 13: 551-559.
44. Groneberg DA, Eynott PR, Lim S, et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 2002; 40: 367-373.
45. Groneberg DA, Eynott PR, Oates T, Lim S, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med 2002; 96: 81-86.
46. Wanner A. Alteration of tracheal mucociliary transport in airway disease. Effect of pharmacologic agents. Chest 1981; 80(6 Suppl): 867-870.
47. Yager J, Chen TM, Dulfano MJ. Measurement of frequency of ciliary beats of human respiratory epithelium. Chest 1978; 73: 627-633.
48. Chen TM, Dulfano MJ. Mucus viscoelasticity and mucociliary transport rate. J Lab Clin Med 1978; 91: 423-431.
49. Svartengren M, Widtskiold-Olsson K, Philipson K, Camner P. Retention of particles on the first bifurcation and the trachea of rabbits. Bull Physiopathol Respir (Nancy) 1981; 17: 87-91.
50. Svartengren K, Wiman LG, Thyberg P, Rigler R. Laser light scattering spectroscopy: a new method to measure tracheobronchial mucocillary activity. Thorax 1989; 44: 539-547.
51. Lee RM, Rossman CM, O'Brodovich H. Assessment of postmortem respiratory ciliary motility and ultrastructure. Am Rev Respir Dis 1987; 136: 445-447.
52. Sibille Y, Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990; 141: 471-501.
53. Stossel TP. Phagocytosis. Clinical disorders of recognition and ingestion. Am J Pathol 1977; 88: 741-751.
54. Ward DM, Hackenyos DP, Kaplan J. Fusion of sequentially internalized vesicles in alveolar macrophages. J Cell Biol 1990; 110: 1013-1022.
55. 2 exposed rabbits. Acta Med Scand Suppl 1967; 473: 1-102.
56. Lauweryns JM, Baert JH. The role of the pulmonary lymphatics in the defenses of the distal lung: morphological and experimental studies of the transport mechanisms of intratracheally instillated particles. Ann NY Acad Sci 1974; 221: 244-275.
57. Lauweryns JM, Baert JH. Alveolar clearance and the role of the pulmonary lymphatics. Am Rev Respir Dis 1977; 115: 625-683.
58. Bailey MR, Fry FA, James AC. The long-term clearance kinetics of insoluble particles from the human lung. Ann Occup Hyg 1982; 26: 273-290.
59. Peiser C, Springer J, Groneberg DA, McGregor GP, Fischer A, Lang RE. Leptin receptor expression in nodose ganglion cells projecting to the rat gastric fundus. Neurosci Lett 2002; 320: 41-44.
60. Fischer TC, Hartmann P, Loser C, et al. Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. J Invest Dermatol 2001; 117: 754-756.
61. Lim S, Groneberg D, Fischer A, et al. Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effect of inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162: 1912-1918.
62. Groneberg DA, Doring F, Eynott PR, Fischer A, Daniel H. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol 2001; 281: G697-G704.
63. Groneberg DA, Doring F, Theis S, Nickolaus M, Fischer A, Daniel H. Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. Am J Physiol Endocrinol Metab 2002; 282: E1172-E1179.